Patricia Kezar, RN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 23a Gatchell Way, Epping, NH 03042 Phone: 603-475-4695 |
Mrs. Kathleen J Higgs, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 26 Calef Hwy, Epping, NH 03042 Phone: 603-969-1005 |
News Archive
In an attempt to decrease the amount of cancer-targeting nanoparticle needed to image tumors, a team of investigators at the Massachusetts General Hospital and Harvard Medical School has developed a simple method for creating iron oxide nanoparticles labeled with 18F, a radioisotope that is easily detected using positron emission tomography (PET). The result is a nanoparticle that can be imaged using PET, computerized tomography (CT), and fluorescence imaging.
Another weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone.
Sexual health research focused on men who have sex with men is lacking, according to health researchers, even in the midst of rising rates of sexually transmitted infections, including HIV, in this population.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
› Verified 4 days ago